Affiliation:
1. Samara State Medical University
2. Samara City Hospital No. 4
3. Ministry of Health of the Samara Region
Abstract
Introduction. Type 2 diabetes is a significant medical problem. The solution to this problem lies not only in lowering the patient’s blood glucose level, but also in preventing the complications of diabetes, influencing insulin resistance and normalizing body weight.Aim. To develop an effective and safe treatment regimen for elderly women with type 2 diabetes, which is aimed at compensating carbohydrate metabolism, improving lipid metabolism and anthropometric parameters.Materials and methods. The study involved 80 women with type 2 diabetes aged 60 to 74 years, who were divided into 2 groups of 40 people. Group 1 included patients with type 2 diabetes receiving traditional therapy for type 2 diabetes. Patients of the group 2 received the method of treatment developed by us, including, in addition to the traditional regimen, the drug Subetta®, cholecalciferol drops. All women collected complaints and anamnesis, assessed anthropometric parameters, glucose, glycated hemoglobin, vitamin D, lipid profile.Results. All patients with type 2 diabetes initially were not compensated for carbohydrate metabolism, had abdominal obesity, atherogenic dyslipidemia, and vitamin D deficiency. Anthropometric parameters significantly improved, glucose and HbA1c levels decreased to target values in patients of group 2 after 6 months against the background of the use of Subetta® and cholecalciferol. Also in this group, the indicators of lipid metabolism improved: the levels of cholesterol, LDL, triglycerides decreased, and the levels of HDL increased. Vitamin D levels reached target range. No episodes of hypoglycemia were recorded.Conclusions. The addition of Subetta® and cholecalciferol to the treatment of patients with type 2 diabetes contributed to the achievement of target indicators of carbohydrate metabolism, improved lipid profile, and weight loss. This method of treatment is well tolerated and has a low risk of hypoglycemia, which is especially important for elderly patients.
Reference26 articles.
1. Дедов И.И., Шестакова М.В., Викулова О.К., Исаков М.А., Железнякова А.В. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. Сахарный диабет. 2019;22(2S):4–61. https://doi.org/10.14341/ DM12208. Dedov I.I., Shestakova M.V., Vikulova O.K., Isakov M.А., Zheleznyakova A.V. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes Mellitus. 2019;22(2S):4–61. (In Russ.) https://doi.org/10.14341/DM12208.
2. Сагирова Р.И., Вербовой А.Ф. Инсулинорезистентность – основа сахарного диабета 2-го типа. РМЖ. 2017;25(14):1039–1042. Режим доступа: https://www.rmj.ru/articles/endokrinologiya/ Insulinorezistentnosty__osnova_saharnogo_diabeta_2-go_tipa/. Sagirova R.I., Verbovoy A.F. Insulin resistance as the basic cause of diabetes mellitus type 2. RMJ. 2017;25(14):1039–1042. (In Russ.) Available at: https://www.rmj.ru/articles/endokrinologiya/Insulinorezistentnosty__osnova_saharnogo_diabeta_2-go_tipa/.
3. Björntorp P., Rosmond R. Visceral obesity and diabetes. Drugs. 1999;58 (Suppl. 1):13–18. https://doi.org/10.2165/00003495-199958001-00005.
4. Оганов Р.Г., Симаненков В.И., Бакулин И.Г., Бакулина Н.В., Барбараш О.Л., Бойцов С.А. и др. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019;18(1):5–66. https://doi.org/10.15829/ 1728-8800-2019-1-5-66. Oganov R.G., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Barbarash O.L., Boytsov S.A. et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention (Russian Federation). 2019;18(1):5–66. (In Russ.) https://doi.org/10.15829/1728- 8800-2019-1-5-66.
5. Булгакова С.В., Башинская С.А. Способ лечения больных пожилого возраста с сахарным диабетом 2 типа. Патент RU 2750523 C1, 29.06.2021. Режим доступа: https://www.elibrary.ru/item.asp?id=46316764. Bulgakova S.V., Bashinskaya S.A. A method for the treatment of elderly patients with type 2 diabetes mellitus. Patent RU 2750523 C1, 29.06.2021. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=46316764.